Bio-Techne Corporation
TECH
Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures biological reagents used in various aspects of life sciā¦ read more
Healthcare
Biotechnology
36 years
USD
Exclusive to Premium users
Price
per share adjusted in USD$63.82
Price+1.38%
$0.87
1Y
Price
Market Cap
$10.004b
Large
Price/Earnings 3y Avg5y Avg
130.2x
Premium
Premium
Financials Overview
Key metrics over the past few years+27.1%
EBITDA Margin+13.3%
Net Profit Margin+7.8%
Free Cash Flow MarginRevenue
$1.217b
-0.2%
1y CAGR+2.3%
3y CAGR+2.4%
5y CAGREarnings
$77.979m
+6.2%
1y CAGR-30.4%
3y CAGR-21.6%
5y CAGREPS
$0.49
+6.5%
1y CAGR-30.0%
3y CAGR-21.0%
5y CAGRBook Value
$1.966b
$2.526b
Assets$560.334m
Liabilities$394.473m
DebtDebt to Assets
15.6%
1.8x
Debt to EBITDAFree Cash Flow
$224.055m
-12.7%
1y CAGR+1.7%
3y CAGR-4.4%
5y CAGRFinancial Reports
Earnings and other important metrics. Amounts in USD.No items found.
Press Releases
Statements and updates from the company